Ex-Insys CEO Pleads Guilty, May Testify In Bribery Trial
By Chris Villani · January 9, 2019, 5:32 PM EST
In an eleventh-hour move, former Insys Therapeutics Inc. CEO Michael Babich admitted to taking part in a scheme to bribe doctors into prescribing the company's pricey fentanyl spray in Massachusetts federal...
To view the full article, register now.